IPHA
Innate Pharma
IPHA
IPHA
8 hedge funds and large institutions have $806K invested in Innate Pharma in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
$481K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
$88.5K |
| 3 |
Millennium Management
New York
|
$119K |
| 4 |
Morgan Stanley
New York
|
$114K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Optiver Holding
Amsterdam,
Netherlands
| $481K | +$274K | +108,423 | +133% |
|
|
2
Millennium Management
New York
| $119K | -$6.27K | -2,477 | -5% |
|
|
3
Morgan Stanley
New York
| $114K | -$5.3K | -2,095 | -4% |
|
|
ETC
4
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $88.5K | -$18.8K | -7,433 | -18% |
|
|
SPIA
5
Steward Partners Investment Advisory
New York
| $1.27K | – | – | – |
|
6
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $518 | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $369 | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$41.7K | -13,281 | Closed |
|